Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.
Seizure. 2024 Oct;121:204-210. doi: 10.1016/j.seizure.2024.08.024. Epub 2024 Aug 30.
The emergence of telemedicine and artificial intelligence (AI) has set the stage for a possible revolution in the future of medicine and neurology including the diagnosis and management of epilepsy. Telemedicine, with its proven efficacy during the COVID-19 pandemic, offers the advantage of bridging the gap between patients in resource-limited areas and specialized care, where in one study telemedicine reduced the epilepsy treatment gap from 43 % to 9 %. AI innovations promise a transformation in epilepsy care by possibly enhancing the accuracy of electroencephalogram (EEG) interpretation and seizure prediction through machine and deep learning. In one study, abnormal EEG recordings were classified into different categories using a convolutional neural networks (CNN) model showing a specificity of 90 % and an accuracy of 88.3 %. Other models constructed to predict seizures have also achieved a sensitivity of 96.8 % and specificity of 95.5 %. Various machine learning (ML) models highlight the potential AI holds in identifying interictal biomarkers and localizing seizure onset zones aiding in epilepsy treatment decision and outcome prediction. An ML model highlighted in this review localized seizure onset zone with an accuracy reaching 73 % and predicted surgical outcomes with an accuracy reaching 79 % compared to the 43 % accuracy of clinicians. However, limitations and challenges hinder the application of such technologies to reach their full potential in epilepsy care. Limitations include access to compatible devices, integration into clinical workflows, data bias, and availability of sufficient data. Extensive validated research is needed to guide future clinical practice with the implementation of technology-enhanced epilepsy care. This narrative review article will explore the use of AI and telemedicine in EEG and epilepsy care, examining their individual and combined impacts in shaping the future of epilepsy care and discussing the challenges and limitations faced in their usage.
远程医疗和人工智能 (AI) 的出现为医学和神经病学的未来带来了一场可能的革命,包括癫痫的诊断和管理。远程医疗在 COVID-19 大流行期间已被证明具有疗效,它具有在资源有限地区的患者和专业护理之间架起桥梁的优势,在一项研究中,远程医疗将癫痫治疗差距从 43%缩小到 9%。AI 创新有望通过机器学习和深度学习来提高脑电图 (EEG) 解释和癫痫发作预测的准确性,从而彻底改变癫痫护理。在一项研究中,使用卷积神经网络 (CNN) 模型将异常脑电图记录分类为不同类别,特异性为 90%,准确性为 88.3%。构建用于预测癫痫发作的其他模型也达到了 96.8%的敏感性和 95.5%的特异性。各种机器学习 (ML) 模型突出了 AI 在识别发作间期生物标志物和定位癫痫发作起始区方面的潜力,有助于癫痫治疗决策和结果预测。本综述中突出的一个 ML 模型以 73%的准确性定位癫痫发作起始区,并以 79%的准确性预测手术结果,而临床医生的准确性仅为 43%。然而,限制和挑战阻碍了这些技术在癫痫护理中充分发挥其潜力。限制包括获得兼容的设备、整合到临床工作流程、数据偏差以及获得足够的数据。需要进行广泛的验证性研究,以指导未来的临床实践,实现技术增强的癫痫护理。本文综述探讨了 AI 和远程医疗在脑电图和癫痫护理中的应用,考察了它们在塑造癫痫护理未来方面的单独和综合影响,并讨论了在使用过程中面临的挑战和局限性。